Andrea Baran
Overview
Explore the profile of Andrea Baran including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
425
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liebman S, Baran A, Barnett T, Campbell T, Chen L, Friedman S, et al.
Nutrients
. 2025 Mar;
17(5).
PMID: 40077649
Background/objectives: Whole-food plant-based diets (WFPBDs) are beneficial in managing hypertension in the general population but have not been well studied in chronic kidney disease (CKD), potentially due to concerns about...
2.
Falsey A, Peterson D, Walsh E, Baran A, Chu C, Branche A, et al.
Res Sq
. 2025 Mar;
PMID: 40060038
Unnecessary antibiotic use is a major driver of antimicrobial resistance, an urgent public health threat. There is an unmet need for improved diagnostics for identifying bacterial etiology in acute respiratory...
3.
LoCastro M, Baran A, Liesveld J, Huselton E, Hill E, Loh K, et al.
JCO Oncol Pract
. 2024 Dec;
:OP2400556.
PMID: 39680824
Purpose: We previously demonstrated that early completion of portable medical orders, known as Medical Orders for Life-Sustaining Treatment (MOLST), was associated with lower-intensity care at the end of life (EOL)...
4.
Friedberg J, Brady M, Strawderman M, Kahl B, Lossos I, Cohen J, et al.
EClinicalMedicine
. 2024 Dec;
78:102959.
PMID: 39677358
Background: There is a significant association between low vitamin D levels at diagnosis of indolent B-cell lymphomas and inferior overall survival (OS). To determine whether supplemental vitamin D improves event-free...
5.
Loh K, Consagra W, Magnuson A, Baran A, Gilmore N, Giri S, et al.
Exp Gerontol
. 2023 Apr;
177:112185.
PMID: 37119835
Background: Elevated markers of inflammation, such as interleukin-6 (IL-6), are associated with aging, cancer, and functional decline. We assessed the association of pre-diagnosis IL-6 levels with post-diagnosis functional trajectories among...
6.
LoCastro M, Sanapala C, Mendler J, Norton S, Bernacki R, Carroll T, et al.
Blood Adv
. 2022 Dec;
7(9):1871-1884.
PMID: 36521100
Older patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) experience intense inpatient health care at the end-of-life stage. Early advance care planning may improve care at the end...
7.
LoCastro M, Sanapala C, Mendler J, Norton S, Bernacki R, Carroll T, et al.
J Geriatr Oncol
. 2022 Sep;
14(1):101374.
PMID: 36100548
Introduction: Older patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) have worse survival rates compared to younger patients, and experience more intense inpatient healthcare at the end of...
8.
Patil A, Baran A, Brehm Z, McCall M, Halushka M
Gigascience
. 2022 Aug;
11.
PMID: 36007182
Background: An incomplete picture of the expression distribution of microRNAs (miRNAs) across human cell types has long hindered our understanding of this important regulatory class of RNA. With the continued...
9.
Melucci A, Lynch O, Wright M, Baran A, Temple L, Poles G, et al.
J Am Med Dir Assoc
. 2022 Mar;
23(4):678-683.e1.
PMID: 35247360
Objective: To assess the narcotic use of older patients after oncologic resection. Design: Retrospective review. Setting And Participants: Adults with neoplasms undergoing resection at a tertiary academic medical center. Methods:...
10.
Liesveld J, Baran A, Azadniv M, Misch H, Nedrow K, Becker M, et al.
Leuk Res
. 2021 Nov;
112:106749.
PMID: 34839054
A phase II study was conducted to ascertain whether sequential exposure to decitabine followed by rapamycin, an mTOR (mechanistic target of rapamycin) inhibitor would result in better responses than decitabine...